Cannasouth Investor Relations Material
Latest events
Investor Day 2023
Cannasouth
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Cannasouth Limited
Access all reports
Cannasouth Limited is a biopharmaceutical company focused on the research, development, and commercialization of medicinal cannabis products. The company operates in areas such as cannabinoid extraction, formulation, and clinical research to create therapeutic products for various health conditions. Cannasouth also engages in cultivation and processing through joint ventures, aiming to ensure high-quality, sustainably produced raw materials for its products. The company is headquartered in Hamilton, New Zealand, and its shares are listed on the NZX.
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
CBD
Country
π³πΏ New Zealand